Trinity Financial Advisors LLC Acquires 234,500 Shares of P3 Health Partners Inc. $PIII

Key Points

• Trinity Financial Advisors LLC increased its stake in P3 Health Partners Inc. by 22.5%, acquiring an additional 234,500 shares to hold a total of 1,278,037 shares, representing approximately 17.80% of the company.
• P3 Health Partners reported an EPS of ($6.23), significantly missing analysts' expectations, with a revenue of $355.79 million for the quarter compared to a forecast of $356.52 million.
• Analyst ratings for P3 Health Partners currently show a consensus rating of "Moderate Buy", with a target price of $16.25 following coverage initiation by Lake Street Capital.

Trinity Financial Advisors LLC raised its holdings in shares of P3 Health Partners Inc. (NASDAQ:PIII - Free Report) by 22.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,278,037 shares of the company's stock after buying an additional 234,500 shares during the quarter. Trinity Financial Advisors LLC owned about 17.80% of P3 Health Partners worth $222,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Cresset Asset Management LLC lifted its holdings in shares of P3 Health Partners by 33.3% during the first quarter. Cresset Asset Management LLC now owns 200,000 shares of the company's stock worth $33,000 after buying an additional 50,000 shares during the last quarter. Abundance Wealth Counselors lifted its holdings in shares of P3 Health Partners by 77.3% during the first quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock worth $66,000 after buying an additional 174,395 shares during the last quarter. Finally, Wealthedge Investment Advisors LLC bought a new stake in shares of P3 Health Partners during the fourth quarter valued at approximately $83,000. 7.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Lake Street Capital began coverage on P3 Health Partners in a research report on Thursday, August 28th. They set a "buy" rating and a $20.00 price objective on the stock. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, P3 Health Partners has a consensus rating of "Moderate Buy" and a consensus price target of $16.25.

P3 Health Partners Stock Performance

Shares of PIII traded down $0.07 on Friday, reaching $8.60. 1,771 shares of the stock traded hands, compared to its average volume of 23,230. The firm has a market cap of $61.83 million, a price-to-earnings ratio of -0.19 and a beta of 0.82. The company has a debt-to-equity ratio of 2.29, a current ratio of 0.31 and a quick ratio of 0.31. P3 Health Partners Inc. has a 12 month low of $5.80 and a 12 month high of $26.99. The stock's 50-day moving average price is $7.26 and its 200-day moving average price is $7.82.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last announced its quarterly earnings results on Thursday, August 14th. The company reported ($6.23) earnings per share for the quarter, missing analysts' consensus estimates of ($3.29) by ($2.94). P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. The company had revenue of $355.79 million during the quarter, compared to the consensus estimate of $356.52 million. P3 Health Partners has set its FY 2025 guidance at EPS. Equities analysts forecast that P3 Health Partners Inc. will post -0.67 EPS for the current fiscal year.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.